ESC 365 - Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

ESC Premium Access

Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

Session: Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

Topic: Comorbidities

Speaker: Professor J. Spinar (Brno, CZ)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Jindrich Spinar

St. Anne University Hospital Brno (FNUSA), Brno (Czechia)

1 presentation

0 follower

9 more presentations in this session

Effect of beta-blockers on mortality in heart failure with mid-range and preserved ejection fraction: a meta-analysis

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Speaker: Professor L. Tumasyan (Yerevan, AM)

The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction

Speaker: Doctor C. Wei-Ting (Tainan, TW)

Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study

Speaker: Doctor K. Tsukamoto (Tokyo, JP)

Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

Speaker: Doctor E. Santas Olmeda (Valencia, ES)

Access the full session

Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

Speakers: Professor J. Spinar, Associate Professor H. Fukuta, Professor L. Tumasyan, Doctor C. Wei-Ting, Doctor K. Tsukamoto...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources